1-85581000-G-T
Variant summary
Our verdict is Likely benign. Variant got -6 ACMG points: 0P and 6B. BP4_ModerateBS2
The ENST00000451137.7(CCN1):c.16G>T(p.Ala6Ser) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000963 in 1,453,618 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
ENST00000451137.7 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -6 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CCN1 | NM_001554.5 | c.16G>T | p.Ala6Ser | missense_variant | 1/5 | ENST00000451137.7 | NP_001545.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CCN1 | ENST00000451137.7 | c.16G>T | p.Ala6Ser | missense_variant | 1/5 | 1 | NM_001554.5 | ENSP00000398736 | P1 | |
CCN1 | ENST00000674743.1 | n.79G>T | non_coding_transcript_exon_variant | 1/4 | ||||||
CCN1 | ENST00000674818.1 | n.86G>T | non_coding_transcript_exon_variant | 1/4 | ||||||
CCN1 | ENST00000676007.1 | n.101G>T | non_coding_transcript_exon_variant | 1/4 |
Frequencies
GnomAD3 genomes Cov.: 33
GnomAD3 exomes AF: 0.0000127 AC: 3AN: 235992Hom.: 0 AF XY: 0.0000156 AC XY: 2AN XY: 128240
GnomAD4 exome AF: 0.00000963 AC: 14AN: 1453618Hom.: 0 Cov.: 31 AF XY: 0.0000152 AC XY: 11AN XY: 722780
GnomAD4 genome Cov.: 33
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Nov 15, 2021 | The c.16G>T (p.A6S) alteration is located in exon 1 (coding exon 1) of the CYR61 gene. This alteration results from a G to T substitution at nucleotide position 16, causing the alanine (A) at amino acid position 6 to be replaced by a serine (S). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at